Drop in Hormone Therapy Leads to Cancer Decline

A decrease in hormone use by women has led to a decline in breast cancer cases, according to new research published in the New England Journal of Medicine this week. On NPR's All Things Considered, host Michele Norris discusses this research with Deborah Grady, MD, MPH, who notes that while there are alternatives to hormone replacement therapy, there are not a lot of good choices for women with severe menopausal symptoms. Grady is professor of epidemiology and biostatistics and of medicine, vice chair of the Department of Epidemiology, co-director of the UCSF Clinical and Translational Science Institute (CTSI), and director of the UCSF Women's Health Clinical Research Center.
The Decrease in Breast-Cancer Incidence in 2003 in the United States Donald A. Berry, et alia New England Journal of Medicine356:1670-1674, April 19, 2007 Abstract | Full Text | Full Text (PDF)
Related Links: Drop in Hormone Therapy Leads to Cancer Decline All Things Considered, NPR, April 19, 2007 The Faces of UCSF: Deborah Grady advancing health worldwide™